Combined PET and X-ray computed tomography imaging in pulmonary infections and inflammation

Current Opinion in Pulmonary Medicine

Volumn 17, Issue 3, 2011, Pages 197-205

  Bomanji, Jamshed ^a   Almuhaideb, Ahmad ^a,b   Zumla, Alimuddin ^c  

^a UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^b KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

^c ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

18F FDG; 68Ga DOTATATE citrate; lung infection; lung inflammation; PET

Indexed keywords

ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; ANTIINFLAMMATORY AGENT; FLUORODEOXYGLUCOSE F 18; GALLIUM 68; GALLIUM CITRATE GA 67; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; SOMATOSTATIN DERIVATIVE;

ARTICLE; AUTORADIOGRAPHY; CANDIDIASIS; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CRYPTOCOCCOSIS; DIAGNOSTIC TEST ACCURACY STUDY; DRUG UPTAKE; HUMAN; LUNG ABSCESS; LUNG INFECTION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PARAGONIMIASIS; PNEUMOCONIOSIS; PNEUMOCYSTOSIS; PNEUMONIA; SARCOIDOSIS; SCINTIGRAPHY; THORAX RADIOGRAPHY; TUBERCULOSIS; TUBERCULOUS LYMPHADENITIS;

FLUORODEOXYGLUCOSE F18; GALLIUM RADIOISOTOPES; HUMANS; PNEUMONIA; POSITRON-EMISSION TOMOGRAPHY; RESPIRATORY TRACT INFECTIONS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 79953889235     PISSN: 10705287     EISSN: 15316971     Source Type: Journal    
DOI: 10.1097/MCP.0b013e328344db8a     Document Type: Article

References (46)

1. Petruzzi N, Shanthly N, Thakur M. Recent trends in soft tissue infection imaging. Semin Nucl Med 2009; 39:115-123. This comprehensive review discusses the current techniques of scintigraphic imaging and also outlines the role of PET imaging in respiratory tract and other infections.
2. Chen DL, Ferkol TW, Mintun MA, et al. Quantifying pulmonary inflammation in cystic fibrosis with positron emission tomography. Am J Respir Crit Care Med 2006; 173:1363-1369. (Pubitemid 43900711)
3. Chakrabarti R, Jung CY, Lee TP, et al. Changes in glucose transport and transporter isoforms during the activation of human peripheral blood lymphocytes by phytohemagglutinin. J Immunol 1994; 152:2660-2668. (Pubitemid 24097960)
4. Jones HA, Marino PS, Shakur BH, Morrell NW. In vivo assessment of lung inflammatory cell activity in patients with COPD and asthma. Eur Respir J 2003; 21:567-573.
5. Yamada S, Kubota K, Kubota R, et al. High accumulation of fluorine-18-fluorodeoxyglucose in turpentine-induced inflammatory tissue. J Nucl Med 1995; 36:1301-1306.
6. Kostakoglu L, Agress H Jr, Goldsmith SJ. Clinical role of FDG PET in evaluation of cancer patients. RadioGraphics 2003; 23:315-340. (Pubitemid 37431265)
7. Amerein PC, Larson SM, Wagner HN Jr. An automated system for measurement of leukocyte metabolism. J Nucl Med 1974; 15:352-355.
8. Alavi A, Gupta N, Alberini JL, et al. Positron emission tomography imaging in nonmalignant thoracic disorders. Semin Nucl Med 2002; 32:293-321. (Pubitemid 35332975)
9. Petrik M, Haas H, Dobrozemsky G, et al. 68Ga-siderophores for PET imaging of invasive pulmonary aspergillosis: proof of principle. J Nucl Med 2010;51:639-645. This study outlines a new PET tracer (68Ga-siderophores) for imaging invasive pulmonary aspergillosis.
10. Bhathena S, Louie J, Schechter GP, et al. Identification of human mononuclear leucocytes bearing receptors for somatostatin and glucagon. Diabetes 1981; 30:127-131. (Pubitemid 11018680)
11. Hiruma K, Koike T, Nakamura H, et al. Somatostatin receptors on human lymphocytes and leukaemia cells. Immunology 1990; 71:480-485.
12. Kwekkeboom DJ, Krenning EP, Lamberts SW. The role of octreotide scintigraphy in clinical diagnosis and therapy. In: Scarpignato C, editor. Octreotide: from basic science to clinical medicine. Progress in basic and clinical pharmacology. Basel: S. Karger Ag; 1996. pp. 281-289.
13. Yang CM, Hsu CH, Lee CM, Wang FC. Intense uptake of [F-18]-fluoro-2 deoxy-D-glucose in active pulmonary tuberculosis. Ann Nucl Med 2003; 17:407-410.
14. Bakheet SM, Powe J, Ezzat A, Rostom A. F-18-FDG uptake in tuberculosis. Clin Nucl Med 1998; 23:739-742. (Pubitemid 28496224)
15. Yago Y, Yukihiro M, Kuroki H, et al. Cold tuberculous abscess identified by FDG PET. Ann Nucl Med 2005; 19:515-518. (Pubitemid 41531274)
16. Sathekge M, Maes A, Kgomo M, et al. Impact of FDG PET on the management of TBC treatment: a pilot study. Nuklearmedizin 2010; 49:35-40.
17. Goo JM, Im JG, Do KH, et al. Pulmonary tuberculoma evaluated by means of FDG PET: findings in 10 cases. Radiology 2000; 216:117-121. (Pubitemid 30434730)
18. Kumar R, Nadig MR, Balakrishnan V, et al. FDG-PET imaging in infection and inflammation. Indian J Nucl Med 2006; 21:104-113.
19. Aziz MA, Wright A, Laszlo A, De Muynck A, et al., for the WHO/International Union Against Tuberculosis And Lung Disease Global Project on Antituberculosis Drug Resistance Surveillance. Epidemiology of antituberculosis drug resistance (the Global Project on Antituberculosis Drug Resistance Surveillance): an updated analysis. Lancet 2006; 368:2142-2154. (Pubitemid 44914009)
20. Vanhagen PM, Krenning EP, Reubi JC, et al. Somatostatin analogue scintigraphy in granulomatous diseases. Eur J Nucl Med 1994; 21:497-502. (Pubitemid 24189411)
21. Bennett JE. Cryptococcosis. In: Braunwald E, Fauci AS, Kasper DL, et al., editors. Harrison's principles of internal medicine, 15th ed. New York: McGraw-Hill; 2001. pp. 1174-1175.
22. Song KD, Lee KS, Chung MP, et al. Pulmonary cryptococcosis: imaging findings in 23 non-AIDS patients. Korean J Radiol 2010; 11:407-416. This study reviews the pattern of FDG PET imaging in patients with pulmonary cryptococcosis and reports that in 2/3 of patients the lung lesions are positive and may mimick malignancy.
23. Huang CJ, You DL, Lee PI, et al. Characteristics of integrated 18F-FDG PET/ CT in pulmonary cryptococcosis. Acta Radiol 2009; 50:374-378.
24. Im JG, Kong Y, Shin YM, et al. Pulmonary paragonimiasis: clinical and experimental studies. RadioGraphics 1993; 13:575-586.
25. Watanabe S, Nakamura Y, Kariatsumari K, et al. Pulmonary paragonimiasis mimicking lung cancer on FDG-PET imaging. Anticancer Res 2003; 23:3437-3440. (Pubitemid 36975446)
26. Lorenzen J, Buchert R, Bleckmann C, et al.Asearch for the focus in patients with fever of unknown origin: is positron-emission tomography with F-18-fluorodeoxyglucose helpful? Rofo Fortschr Geb Rontgenstr Neuen Bildgeb Verfahr 1999; 171:49-53.
27. 18F-fluorodeoxyglucose uptake on positron emission tomography scan. Geriatr Gerontol Int 2010; 10:251-254.
28. Brudin LH, Valind SO, Rhodes CG, et al. Fluorine-18 deoxyglucose uptake in sarcoidosis measured with positron emission tomography. Eur J Nucl Med 1994; 21:297-305. (Pubitemid 24106447)
29. 67Ga scintigraphy in patients with sarcoidosis. J Nucl Med 2006; 47:1571-1576.
30. Braun JJ, Kessler R, Constantinesco A, Imperiale A. F-FDG PET/CT in sarcoidosis management: review and report of 20 cases. Eur J Nucl Med 2008; 35:1537-1540.
31. Teirstein AS, Machac J, Almeida O, et al. Results of 188 whole-body fluorodeoxyglucose positron emission tomography scans in 137 patients with sarcoidosis. Chest 2007; 132:1949-1953.
32. Meller J, Sahlmann CO, Scheel AK. 18F-FDG PET a PET/CT in fever of unknown origin. J Nucl Med 2007; 48:35-45. (Pubitemid 47555372)
33. Kwekkeboom DJ, Krenning EP, Kho GS, et al. Somatostatin receptor imaging in patients with sarcoidosis. Eur J Nucl Med 1998; 25:1284-1292. (Pubitemid 28446055)
34. Speizer FE. Environmental lung diseases. In: Braunwald E, Fauci AS, Kasper DL, et al., editors. Harrison's principles of internal medicine, 15th ed. New York: McGraw-Hill; 2001. pp. 1470-1471.
35. 18F-FDG PET imaging of progressive massive fibrosis. Ann Nucl Med 2010; 24:21-27.
36. Reichert M, Bensadoun ES. PET imaging in patients with coal workers pneumoconiosis and suspected malignancy. J Thorac Oncol 2009; 4:649-651.
37. Rodrigues RS, Miller PR, Bozza FA, et al. FDG-PET in patients at risk for acute respiratory distress syndrome: a preliminary report. Intensive Care Med 2008; 34:2273-2278.
38. Klein M, Cohen-Cymberknoh M, Armoni S, et al. 18F-fluorodeoxyglucose-PET/ CT imaging of lungs in patients with cystic fibrosis. Chest 2009; 136:1220-1228. The authors report the advantage of using FDG PET imaging to monitor the effects of treatment in patients with cystic fibrosis with focal infections or inflammatory processes.
39. Buchler T, Bomanji J, Lee SM. FDG-PET in bleomycin-induced pneumonitis following ABVD chemotherapy for Hodgkin's disease: a useful tool for monitoring pulmonary toxicity and disease activity. Haematologica 2007; 92:e120-e121.
40. Jones H, Donovan T, Goddard MJ, et al. Use of 18 FDG-PET to discriminate between infection and rejection in lung transplant recipients. Transplantation 2004; 77:1462-1464. (Pubitemid 38668446)
41. Ozsahin H, Von Planta M, Muller I, et al. Successful treatment of invasive aspergillosis in chronic granulomatous disease by bone marrow transplantation, granulocyte colony-stimulating factor-mobilized granulocytes, and liposomal amphotericin-B. Blood 1998; 92:2719-2724. (Pubitemid 28469084)
42. Wyss MT, Honer M, Spath N, et al. Influence of ceftriaxone treatment on FDG uptake: an in vivo [18F]-fluorodeoxyglucose imaging study in soft tissue infections in rats. Nucl Med Biol 2004; 31:875-882.
43. Bleeker-Rovers CP, Warris A, Drenth JP, et al. Diagnosis of Candida lung abscesses by 18F fluorodeoxyglucose positron emission tomography. Clin Microbiol Infect 2005; 11:493-495. (Pubitemid 40744397)
44. Win Z, Todd J, Al-Nahhas A. FDG-PET imaging in Pneumocystis carinii pneumonia. Clin Nucl Med 2005; 30:690-691. (Pubitemid 41361764)
45. 18F] Fluorodeoxyglucose positron emission tomography for lung antiinflammatory response evaluation. Am J Respir Crit Care Med 2009; 180:533-539.
46. Harkirat S, Anand SS, Indrajit IK, Dash AK. Pictorial essay: PET/CT in tuberculosis. Indian J Radiol Imaging 2008; 18:141-147. (Pubitemid 351550798)